UNSPSC 51383508: Indomethacin sodium

This classification denotes a cyclooxygenase inhibitor with the molecular formula C19H15ClNO4.Na.3H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0IMX38M2GG, chemically known as 1h-indole-3-acetic acid, 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-, sodium salt, trihydrate but more generally known as indometacin sodium, which bears US NIH Compound Identifier 156283. Most nations, for tariff and trade purposes, schedule indomethacin sodium under HS 29339990.

As of Q4 2014, INDOMETHACIN SODIUM remains US FDA's Preferred Term for this commodity. Indomethacin sodium bears US NLM identifiers UMLS ID C0982211 and NCI Concept Code C47999. SMILES: CC1C(C2CC(CCC2N1C(=O)C3CCC(CC3)CL)OC)CC(=O)[O-].O.O.O.[NA+].

UNSPSC 51383508 Indomethacin sodium is a Commodity code that appears in state and local procurement systems with minimal recent activity aligned to its nominal pharmaceutical scope. The single recent opportunity in the active pipeline is Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026, which solicits naloxone and drug deactivation systems—products outside the indomethacin category—suggesting a classification mismatch rather than genuine demand for indomethacin sodium under this code. The county procurement does not reflect purchasing of the nonsteroidal anti-inflammatory medication the code nominally describes.

Seminole County's naloxone and drug deactivation systems procurement, with a response deadline of July 26, 2023, targets 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The IFB requires electronic bid submission, drug-free workplace certification, E-Verify compliance, and includes a three-month probationary termination period; the contract carries a two-year initial term with an optional one-year renewal. This single identified opportunity does not establish a pattern of state and local procurement under UNSPSC 51383508 for indomethacin sodium itself, and the code shows no corroborating recent activity in other jurisdictions or states. Business development professionals should confirm whether indomethacin sodium procurement activity exists under this code in their target markets before committing resources to pursuit strategies.